Rhodiola Rosea After 40: What the Research Says
Rhodiola rosea, sometimes called golden root or roseroot, is one of the best-studied "adaptogens." After 40, many people juggle demanding careers, family, training and less forgiving recovery, so a supplement promising better stress resilience sounds appealing. Our editorial team looked at what the trials show, where the evidence is thin, and what changes with age.
What rhodiola is
Rhodiola rosea is a flowering plant that grows in cold, high-altitude regions of Europe, Asia and North America. Its root has been used in Scandinavian and Russian folk medicine for centuries to reduce fatigue and improve work capacity.
The compounds most often linked to its effects are rosavins (rosavin, rosarin and rosin) and salidroside. Quality extracts are typically standardized to about 3% rosavins and 1% salidroside, a ratio that reflects the natural composition of Rhodiola rosea root and helps distinguish it from other Rhodiola species.
The term "adaptogen" describes a substance said to increase the body's resistance to stress without disrupting normal function. It is a traditional rather than a strict pharmacological category. Proposed mechanisms for rhodiola include effects on the stress-hormone axis (the HPA axis), on cellular stress-response proteins and on neurotransmitters such as serotonin and dopamine.
In the US, rhodiola is sold as a dietary supplement. It is not an FDA-approved drug for any condition, and products vary widely in content and quality.
Why the over-40 group is interested
Midlife brings specific challenges. Sleep often becomes lighter, perimenopause and menopause change energy and mood in women, and many men notice a slower recovery from hard training. Chronic work stress peaks for many people in their 40s and 50s.
The trials that matter most here are those on stress-related fatigue and burnout-like symptoms, because they enrolled working adults, often in that age range. A placebo-controlled study by Olsson and colleagues (2009) used the standardized extract SHR-5 in adults with stress-related fatigue and reported improvements in fatigue scores and attention over 28 days.
Rhodiola has also been studied for mild to moderate depression. A trial by Darbinyan et al. (2007) found improvements versus placebo, and a later study by Mao et al. (2015) compared rhodiola with sertraline: the drug produced larger improvements, but rhodiola caused fewer side effects. These are small studies and are not a basis for self-treating depression.
Rhodiola and training
For endurance performance, results are mixed. Some acute-dose studies reported modest improvements in time-trial performance or perceived exertion, for example Noreen et al. (2013), while others found no meaningful effect.
There is little evidence that rhodiola increases strength or muscle mass. Its potential value for a lifter over 40 lies more in coping with life stress that interferes with training than in any direct effect on muscle.
Systematic reviews are cautious. Hung, Perry and Ernst (2011) and Ishaque et al. (2012) both noted that many trials had methodological weaknesses and that the overall evidence for fatigue was suggestive but inconclusive.
A realistic expectation: some people notice they feel less frazzled and more mentally clear during demanding periods; others notice nothing. It will not replace sleep, sensible programming or nutrition.
Doses, timing and safety
Studies have generally used standardized extracts in the range of roughly 200 to 600 mg per day, often split into one or two doses taken in the morning or early afternoon. Because rhodiola can feel mildly stimulating, evening use may disturb sleep in some people.
| Aspect | Practical point |
|---|---|
| Standardization | Look for Rhodiola rosea standardized to rosavins and salidroside |
| Study dose range | About 200–600 mg/day of extract |
| Timing | Morning or early afternoon, often on an empty stomach |
| Onset | Some trials report effects within 1–4 weeks |
| Quality | Third-party testing; beware products labeled only "Rhodiola" without species |
Side effects in trials were usually mild: dizziness, dry mouth, jitteriness or sleep disturbance. Several groups should talk with a clinician first:
- People taking antidepressants (SSRIs, SNRIs, MAOIs) or other psychiatric medications;
- Those with bipolar disorder, because stimulating supplements can potentially trigger mania;
- People on blood pressure or diabetes medication, given reports of effects on these parameters;
- Pregnant or breastfeeding women, for whom safety data are lacking.
Adulteration is a real issue. Analyses of commercial products have found some that contained little rosavin or were made from other Rhodiola species. Choosing a third-party tested product reduces, but does not eliminate, that risk.
Conclusions from the editorial team
Rhodiola rosea has a modest but genuine evidence base for stress-related fatigue, which is the most relevant use for busy adults over 40. Evidence for athletic performance is weaker and inconsistent.
If you try it, choose a standardized Rhodiola rosea extract, stay within the dose ranges used in studies, take it earlier in the day, and give it a few weeks before judging.
Check with a clinician if you take psychiatric, blood pressure or diabetes medication. Persistent fatigue or low mood deserves a medical evaluation rather than supplements alone.
Related reading on our site: training after 50, magnesium for women, and how to prepare for an SHBG blood test.
References
- Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17(7):481–493.
- Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009;75(2):105–112.
- Darbinyan V, Aslanyan G, Amroyan E, et al. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry. 2007;61(5):343–348.
- Mao JJ, Xie SX, Zee J, et al. Rhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trial. Phytomedicine. 2015;22(3):394–399.
- Hung SK, Perry R, Ernst E. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine. 2011;18(4):235–244.
- Ishaque S, Shamseer L, Bukutu C, Vohra S. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complement Altern Med. 2012;12:70.
- Noreen EE, Buckley JG, Lewis SL, et al. The effects of an acute dose of Rhodiola rosea on endurance exercise performance. J Strength Cond Res. 2013;27(3):839–847.
